A Study of DF6002 Alone and in Combination With Nivolumab
Clinical trial NCT04423029 · COMPLETED
Trial details
- NCT number
- NCT04423029
- Sponsor
- Dragonfly Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-13
- Primary completion
- 2025-11-26
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.